Formal Test 5  

Formal Test 5Formal Test 5Formal Test 5

Formal Test 7  

Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7

Formal Test 6

Formal Test 6Formal Test 6Formal Test 6Formal Test 6Formal Test 6Formal Test 6Formal Test 6

Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas (CIRTUSARC)

The study is a Phase 2 clinical trial of the drug cirtuvivint as a second-line treatment for advanced soft tissue sarcomas. The study is being conducted in Spain and is expected to enroll approximately 25 patients in total. The primary objective of this Phase 2 study is to evaluate the …

A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

This study will evaluate the efficacy of tiragolumab plus atezolizumab and carboplatin and etoposide (CE) compared with placebo plus atezolizumab and CE in participants with chemotherapy-naive extensive-stage small cell lung cancer (ES-SCLC). Eligible participants will be randomized in a 1:1 ratio to receive one of the following treatment regimens during …

A Study Evaluating The Safety Tolerability Pharmacokinetics And Efficacy Of Venetoclax In Combination With Atezolizumab Carboplatin And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).

A study consisting of a dose-escalation phase and a dose-expansion phase to evaluate the safety, tolerability, pharmacokinetics, and efficacy of venetoclax in combination with atezolizumab, carboplatin, and etoposide.

None

None

None

None